Question explored with the scientific record
dandelion root?
The short version: dandelion root has never been shown to treat or prevent cancer in a single person. Every cancer result here is cells in a dish or tumors in mice.
The human-relevant evidence is thin. The melanoma work killed A375 cells at 2.5 mg/mL and spared normal fibroblasts and immune cells [1], and the prostate study shrank tumors in mice at 40 mg/kg/day [2]. The breast study is a dish experiment on one cell line, with an IC50 around 0.8 to 1.6 mg/mL depending on time [4]. None of that is a person. A dish concentration is not a dose you can swallow and reach a tumor.
| Study | Model | Result |
|---|---|---|
| Melanoma [1] | Human cells in dish | Killed cancer cells, spared normal cells |
| Prostate [2] | Mice with tumors | Tumor burden fell at 40 mg/kg/day |
| Breast [4] | Human cells in dish | Slowed growth, induced cell death |
The rest of what surfaced is unrelated to cancer: a liver-fibrosis mouse study [5], a diuretic study that found no diuretic effect [6], and a prebiotic fermentation paper [3]. That is a fact about this search, not about the plant.
What is missing is the only thing that would matter: a human trial with a real outcome, and long-term safety data. Dandelion is a food, so the risk is low, but supplement quality is unregulated and extracts vary wildly. Do not take it instead of cancer treatment.
My call: dandelion root is a plausible lab hypothesis with zero human cancer evidence, so it is not a cancer treatment or prevention. Confidence: high that the human evidence is absent, low on any benefit.
Sources used 6
-
The Efficacy of Dandelion Root Extract in Inducing Apoptosis in Drug‐Resistant Human Melanoma Cells
Dandelion root extract induces apoptosis in A375 human melanoma cells with little toxicity to normal cells and sensitizes resistant G361 melanoma when combined with metformin.
DOI: 10.1155/2011/129045 -
Dandelion Root and Lemongrass Extracts Induce Apoptosis, Enhance Chemotherapeutic Efficacy, and Reduce Tumour Xenograft Growth In Vivo in Prostate Cancer
Dandelion root aqueous extract (DRE) and lemongrass ethanolic extract (LGE) induce apoptosis in prostate cancer cells, selectively spare normal cells, synergize with certain chemotherapies in vitro, and reduce tumor growth in prostate cancer xenografts in vivo, supporting their …
DOI: 10.1155/2019/2951428 -
OPTIMIZATION OF PREBIOTIC RATIO FOR IMPROVED BSH ACTIVITY OF ENTEROCOCCUS FAECALIS CGZ3
Optimization of a plant-based prebiotic blend (Taraxacum officinale root extract with sorbitol and maltitol) using OFAT and Box-Behnken design to boost bile salt hydrolase activity in Enterococcus faecalis CGz3, suggesting a synbiotic route for cholesterol reduction.
DOI: 10.55251/jmbfs.12411 -
Mechanistic Study on the Inhibitory Effect of Dandelion Extract on Breast Cancer Cell Proliferation and Its Induction of Apoptosis
An in vitro mechanistic study showing that the Ethyl Acetate fraction EA-2 of dandelion root extract inhibits proliferation of MDA-MB-231 breast cancer cells, induces apoptosis and S-phase arrest, and modulates multiple signaling pathways (PI3K-Akt, JAK-STAT, PPAR) via multi-tar…
DOI: 10.3390/biology14080910 -
Antifibrotic activity of Taraxacum officinale root in carbon tetrachloride-induced liver damage in mice
This study investigates the antifibrotic effects of Taraxacum officinale root extract in a mouse model of carbon tetrachloride-induced liver damage, demonstrating its potential to restore liver function and structure.
DOI: 10.1016/j.jep.2010.05.046 -
Evaluation of Dandelion for Diuretic Activity and Variation in Potassium Content
This study evaluates the diuretic activity of dandelion (Taraxacum officinale) extracts and assesses the variation in potassium content in its leaves and roots, finding no significant diuretic effect and consistent mineral content over time.
DOI: 10.3109/13880209309082914